The U.S. Food and Drug Administration has launched a nationwide supply control recall due to a packaging error.
Apotex Corporation has recalled 4 loads of Drospirenone and Ethinyl Estradiol supply control pills because of the tablets may have been organized incorrectly or might probably be missing, the FDA launched Monday.
Because of the error, ladies may uncover themselves mistakingly missing a pill or taking a placebo as an alternative of an brisk pill, which might result in pregnancy. “As a result of this packaging error, where a patient does not take a tablet due to a missing tablet or that a patient takes a placebo instead of an active tablet, loss of efficacy is possible due to variation in the dosage consumed,” the FDA recall reads.
As of Monday, there ha been no critiques of any antagonistic outcomes or unintended pregnancies, in accordance with the FDA.
An stock of the affected heaps, which all have an expiration date of August 2020, is likely to be reviewed proper right here. View an incorrectly organized Apotex supply control pack underneath:
Apotex has moreover notified places the place the pills had been shipped and has organized for them to be returned.